Results 1 to 10 of about 401,802 (297)

HEPATITIS D: A REVIEW

open access: yesJournal of the Dow University of Health Sciences, 2007
Hepatitis D has been show n to he reducing in frequency in the Western countries com m ensurate with HBV decline while recent reports from Pakistan are indicating a rising frequency.
Bader Faiyaz Zuberi
doaj   +5 more sources

Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative Review [PDF]

open access: yesMicroorganisms
More than 12 million individuals worldwide are chronically infected with the hepatitis D virus (HDV). HDV infection is the most severe form of viral hepatitis since it requires hepatitis B virus co-infection and accelerates progression to cirrhosis and ...
Poonam Mathur   +2 more
doaj   +2 more sources

Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey [PDF]

open access: yesJournal of Preventive Medicine and Public Health, 2022
Objectives Infections with hepatitis B, C, and D virus (HBV, HCV, and HDV) are a major public health problem and lead to serious complications such as cirrhosis and hepatocellular carcinoma. We aimed to determine the seroprevalence of hepatitis B surface
Davaalkham Dambadarjaa   +10 more
doaj   +1 more source

A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape

open access: yesViruses, 2023
Chronic hepatitis B virus (HBV) infection is a global health threat. Mutations in the surface antigen of HBV (HBsAg) may alter its antigenicity, infectivity, and transmissibility.
Felix Lehmann   +9 more
doaj   +1 more source

Hepatitis D: advances and challenges

open access: yesChinese Medical Journal, 2022
Abstract Hepatitis D virus (HDV) infection causes the most severe form of viral hepatitis with rapid progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Although discovered > 40 years ago, little attention has been paid to this pathogen from both scientific and public communities.
Zhijiang Miao   +4 more
openaire   +3 more sources

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection

open access: yesViruses, 2022
The Na+/taurocholate co-transporting polypeptide (NTCP, gene symbol SLC10A1) is both a physiological bile acid transporter and the high-affinity hepatic receptor for the hepatitis B and D viruses (HBV/HDV).
Massimo Palatini   +13 more
doaj   +1 more source

Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors

open access: yesViruses, 2021
Identification of Na+/taurocholate co-transporting polypeptide (NTCP) as high-affinity hepatic entry receptor for the Hepatitis B and D viruses (HBV/HDV) opened the field for target-based development of cell-entry inhibitors. However, most of the HBV/HDV
Michael Kirstgen   +7 more
doaj   +1 more source

Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac

open access: yesVaccines, 2021
Background and aims: Peripartum transmission of hepatitis B virus (HBV) from an infected mother to the child can be prevented in most but not all cases by immediate vaccination of the newborn.
Rifaat Safadi   +13 more
doaj   +1 more source

Prevalence of hepatitis D virus among HBsAg-positive individuals,2015-2016: Azar cohort study [PDF]

open access: yesHealth Promotion Perspectives, 2020
Background: Hepatitis D virus (HDV) is a defective RNA pathogen that requires the presence of the hepatitis B virus (HBV) for infection. Middle East countries are endemic areas for HDV infection.
Ali Asghar Pouri   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy